Digostics Launches University Trial for At-Home Type 1 Diabetes Test
Researchers at Yale School of Medicine, funded by Breakthrough T1D, are evaluating GTT@home, a new...
PathoCare Accepts Tender Offer at $500M, Plans New Equity Round
PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC (a leader in the...
Biocytogen, BeOne Sign Antibody Licensing Deal for Drug R&D
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the...
Cancer Milestones Accelerate as Regulators Shift Focus
Issued on behalf of Oncolytics Biotech Inc. As lawmakers weigh potential cuts to scientific research funding,...
Nature Medicine Publishes Phase 1 Results of Innovent’s IBI343 ADC
Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam
GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has...